Loading...
Market
Will Eli Lilly's stock price increase within 3 months following successful Phase 3 trials announcement?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data and financial news outlets
Story
Eli Lilly's Weekly Insulin Efsitora Effective in Type 2 Diabetes Trials
May 16, 2024, 12:29 PM
Eli Lilly announced on Thursday that its once-weekly insulin injection, efsitora, met the main goals in two late-stage trials evaluating its effectiveness in people with type 2 diabetes. The experimental insulin demonstrated blood sugar reduction consistent with commonly used daily basal insulin products. These results suggest that efsitora could offer a significant lifestyle improvement for patients by reducing the frequency of injections from daily to weekly.
View original story
Similar markets
Increase by 5% or more • 50%
Increase by less than 5% or decrease • 50%
Yes • 50%
No • 50%
Stock Price Increases • 33%
Stock Price Decreases • 33%
Stock Price Remains Stable • 34%
Significant stock value increase • 33%
Moderate stock value increase • 33%
No significant change • 34%
Stock price increase • 50%
Stock price decrease • 50%
